MAP kinase activation (Homo sapiens)

From WikiPathways

Revision as of 14:12, 8 May 2014 by Anwesha (Talk | contribs)
Jump to: navigation, search
8, 16, 18, 21712, 141, 3, 9, 152, 13, 235, 1474, 11, 192, 13, 23, 25710, 23, 245, 257cytosolphospho-p38 MAPK phospho MAPKAPK2 or phospho MaPKAPK3 hp-IRAK1K6 poly-Ub oligo-TRAF6 TAB2/3 Activated TAK complexes pUb-TRAF6TAB1TAB2/TAB3free polyubiquitin chain phospho-TAK1 p38 MAPKMAPKAPK2/3 PAMPNOD oligomer MAPKAP2/3 p-MAPK p38 alpha/beta MEK1ERK-1 MKK3/MKK6 phospho-ERK-1MEK1 MDPNOD2 nucleoplasmPAMPNOD oligomerK63-Ub-RIP2 TAB2/3 Active MAPKAP kinase phospho-p38 MAPK MAPKAPK2/3 Phospho-p38 MAPK alpha/beta phospho-ERK-1 dimer p-MAPK p38 alpha/beta PAMPNOD oligomerK63-polyUb-RIP2NEMOactivated TAK1 complex MAPKAP2/3 phospho-ERK-2MEK2 phospho-ERK-1 dimer NOD1iE-DAP NOD1iE-DAP oligomer phospho-ERK-2 dimer p-MKK3/p-MKK6 MDPNOD2 oligomer p-MKK3/p-MKK6 phospho-p38 MAPKp-MAPKAPK2/3 phospho-ERK-2 dimer p-IRAK2K63-linked pUb oligo-TRAF6free K63-linked pUbp-TAK1complex MEK2ERK-2 PAMPNOD oligomerK63-polyUb-RIP2NEMO TAK1 complex Active MAPKAP kinase hp-IRAK1K6-poly-Ub oligo-TRAF6Activated TAK1 complex MAP kinase p38 alpha/beta hp-IRAK1K6-polyUb TRAF6 p-IRAK2K63-linked pUb oligo-TRAF6 p-S,T-MAP2K2p-MAPK8/9/10iE-DAP MAPK14 phospho-ERK-1 dimerphospho-ERK-2 dimerMAPK11 ADPNOD1 phospho-ERK-1MEK1MAPK targets/ Nuclear events mediated by MAP kinasesATPADPp-T222,S272,T334-MAPKAPK2 MDP ATPp-T185,Y187-MAPK1 TAB3MAPKAPK2 MEK1ERK-1p-S218,S222-MAP2K1 p-T185,Y187-MAPK1 ADPphospho-p38 MAPK MAPKAPK2/3ATPK63polyUb TRAF6 p-T202,Y204-MAPK3 MEK1p-S,2T-MAPKAPK3 p-IRAK2 NOD2 p-T180,Y182-MAPK11 MAPK1MKK4/MKK7MEK2ERK-2p-S218,S222-MAP2K1 p38 MAPKMAPKAPK2/3ADPMKK3/MKK6ADPp-T185,Y187-MAPK1 ATPMAPK8/9/10phospho-ERK-2 dimerIKBKG phospho-ERK-2MEK2MAPKAPK3 p-T202,Y204-MAPK3 Activated TAK complexesp-T202,Y204-MAPK3p-S,T-MAP2K2 ATPp-T161-CDK1MAPKAPK3 p-S218,S222-MAP2K1ADPp-T180,Y182-MAPK14 ATPMAP3K7 p-MAPK8/9/10ATPp-MKK3/p-MKK6Ub-209-RIPK2 p-MAP2K4/p-MAP2K7TAB2 p-T180,Y182-MAPK11 phospho-ERK-1 dimerp-MKK3/p-MKK6MAPKAPK2 phospho-p38 MAPKp-MAPKAPK2/3p-T184,T187-MAP3K7 TAB2 p-S,T-MAP2K2 phospho-p38 MAPK phospho MAPKAPK2 or phospho MaPKAPK3TAB3ADPMAPK3p-MEK1p-T180,Y182-MAPK14 p-2S,S376,T,T209,T387-IRAK1 ATPMAPK1 p-T202,Y204-MAPK3 p-T222,S272,T334-MAPKAPK2 TAB1 p-T180,Y182-MAPK14 MAPK3 ADPp-T185,Y187-MAPK1p-S,2T-MAPKAPK3 p-T180,Y182-MAPK11 206, 17, 22


Description

The mitogen activated protein kinase (MAPK) cascade, one of the most ancient and evolutionarily conserved signaling pathways, is involved in many processes of immune responses. The MAP kinases cascade transduces signals from the cell membrane to the nucleus in response to a wide range of stimuli (Chang and Karin, 2001; Johnson et al, 2002).

There are three major groups of MAP kinases

  • the extracellular signal-regulated protein kinases ERK1/2,
  • the p38 MAP kinase
  • and the c-Jun NH-terminal kinases JNK.
<p>ERK1 and ERK2 are activated in response to growth stimuli. Both JNKs and p38-MAPK are activated in response to a variety of cellular and environmental stresses. The MAP kinases are activated by dual phosphorylation of Thr and Tyr within the tripeptide motif Thr-Xaa-Tyr. The sequence of this tripeptide motif is different in each group of MAP kinases: ERK (Thr-Glu-Tyr); p38 (Thr-Gly-Tyr); and JNK (Thr-Pro-Tyr).<p>MAPK activation is mediated by signal transduction in the conserved three-tiered kinase cascade: MAPKKKK (MAP4K or MKKKK or MAPKKK Kinase) activates the MAPKKK. The MAPKKKs then phosphorylates a dual-specificity protein kinase MAPKK, which in turn phosphorylates the MAPK.<p>The dual specificity MAP kinase kinases (MAPKK or MKK) differ for each group of MAPK. The ERK MAP kinases are activated by the MKK1 and MKK2; the p38 MAP kinases are activated by MKK3, MKK4, and MKK6; and the JNK pathway is activated by MKK4 and MKK7. The ability of MAP kinase kinases (MKKs, or MEKs) to recognize their cognate MAPKs is facilitated by a short docking motif (the D-site) in the MKK N-terminus, which binds to a complementary region on the MAPK. MAPKs then recognize many of their targets using the same strategy, because many MAPK substrates also contain D-sites.<p>The upstream signaling events in the TLR cascade that initiate and mediate the ERK signaling pathway remain unclear. Original Pathway at Reactome: http://www.reactome.org/PathwayBrowser/#DB=gk_current&FOCUS_SPECIES_ID=48887&FOCUS_PATHWAY_ID=450294</div>

Try the New WikiPathways

View approved pathways at the new wikipathways.org.

Quality Tags

Ontology Terms

 

Bibliography

View all...
  1. Johnson GL, Lapadat R.; ''Mitogen-activated protein kinase pathways mediated by ERK, JNK, and p38 protein kinases.''; PubMed Europe PMC Scholia
  2. Ben-Levy R, Leighton IA, Doza YN, Attwood P, Morrice N, Marshall CJ, Cohen P.; ''Identification of novel phosphorylation sites required for activation of MAPKAP kinase-2.''; PubMed Europe PMC Scholia
  3. Lang V, Janzen J, Fischer GZ, Soneji Y, Beinke S, Salmeron A, Allen H, Hay RT, Ben-Neriah Y, Ley SC.; ''betaTrCP-mediated proteolysis of NF-kappaB1 p105 requires phosphorylation of p105 serines 927 and 932.''; PubMed Europe PMC Scholia
  4. Gantke T, Sriskantharajah S, Ley SC.; ''Regulation and function of TPL-2, an IκB kinase-regulated MAP kinase kinase kinase.''; PubMed Europe PMC Scholia
  5. ter Haar E, Prabhakar P, Liu X, Lepre C.; ''Crystal structure of the p38 alpha-MAPKAP kinase 2 heterodimer.''; PubMed Europe PMC Scholia
  6. Dong C, Davis RJ, Flavell RA.; ''MAP kinases in the immune response.''; PubMed Europe PMC Scholia
  7. Deacon K, Blank JL.; ''Characterization of the mitogen-activated protein kinase kinase 4 (MKK4)/c-Jun NH2-terminal kinase 1 and MKK3/p38 pathways regulated by MEK kinases 2 and 3. MEK kinase 3 activates MKK3 but does not cause activation of p38 kinase in vivo.''; PubMed Europe PMC Scholia
  8. Sundarrajan M, Boyle DL, Chabaud-Riou M, Hammaker D, Firestein GS.; ''Expression of the MAPK kinases MKK-4 and MKK-7 in rheumatoid arthritis and their role as key regulators of JNK.''; PubMed Europe PMC Scholia
  9. Cho J, Melnick M, Solidakis GP, Tsichlis PN.; ''Tpl2 (tumor progression locus 2) phosphorylation at Thr290 is induced by lipopolysaccharide via an Ikappa-B Kinase-beta-dependent pathway and is required for Tpl2 activation by external signals.''; PubMed Europe PMC Scholia
  10. Belich MP, Salmerón A, Johnston LH, Ley SC.; ''TPL-2 kinase regulates the proteolysis of the NF-kappaB-inhibitory protein NF-kappaB1 p105.''; PubMed Europe PMC Scholia
  11. Bogoyevitch MA, Kobe B.; ''Uses for JNK: the many and varied substrates of the c-Jun N-terminal kinases.''; PubMed Europe PMC Scholia
  12. Cohen S, Achbert-Weiner H, Ciechanover A.; ''Dual effects of IkappaB kinase beta-mediated phosphorylation on p105 Fate: SCF(beta-TrCP)-dependent degradation and SCF(beta-TrCP)-independent processing.''; PubMed Europe PMC Scholia
  13. Sithanandam G, Latif F, Duh FM, Bernal R, Smola U, Li H, Kuzmin I, Wixler V, Geil L, Shrestha S.; ''3pK, a new mitogen-activated protein kinase-activated protein kinase located in the small cell lung cancer tumor suppressor gene region.''; PubMed Europe PMC Scholia
  14. Handoyo H, Stafford MJ, McManus E, Baltzis D, Peggie M, Cohen P.; ''IRAK1-independent pathways required for the interleukin-1-stimulated activation of the Tpl2 catalytic subunit and its dissociation from ABIN2.''; PubMed Europe PMC Scholia
  15. Raingeaud J, Whitmarsh AJ, Barrett T, Dérijard B, Davis RJ.; ''MKK3- and MKK6-regulated gene expression is mediated by the p38 mitogen-activated protein kinase signal transduction pathway.''; PubMed Europe PMC Scholia
  16. Heissmeyer V, Krappmann D, Hatada EN, Scheidereit C.; ''Shared pathways of IkappaB kinase-induced SCF(betaTrCP)-mediated ubiquitination and degradation for the NF-kappaB precursor p105 and IkappaBalpha.''; PubMed Europe PMC Scholia
  17. Roskoski R.; ''ERK1/2 MAP kinases: structure, function, and regulation.''; PubMed Europe PMC Scholia
  18. Lang V, Symons A, Watton SJ, Janzen J, Soneji Y, Beinke S, Howell S, Ley SC.; ''ABIN-2 forms a ternary complex with TPL-2 and NF-kappa B1 p105 and is essential for TPL-2 protein stability.''; PubMed Europe PMC Scholia
  19. Ben-Levy R, Hooper S, Wilson R, Paterson HF, Marshall CJ.; ''Nuclear export of the stress-activated protein kinase p38 mediated by its substrate MAPKAP kinase-2.''; PubMed Europe PMC Scholia
  20. Arthur JS, Ley SC.; ''Mitogen-activated protein kinases in innate immunity.''; PubMed Europe PMC Scholia
  21. Lukas SM, Kroe RR, Wildeson J, Peet GW, Frego L, Davidson W, Ingraham RH, Pargellis CA, Labadia ME, Werneburg BG.; ''Catalysis and function of the p38 alpha.MK2a signaling complex.''; PubMed Europe PMC Scholia
  22. Wang X, Nadarajah B, Robinson AC, McColl BW, Jin JW, Dajas-Bailador F, Boot-Handford RP, Tournier C.; ''Targeted deletion of the mitogen-activated protein kinase kinase 4 gene in the nervous system causes severe brain developmental defects and premature death.''; PubMed Europe PMC Scholia
  23. Raingeaud J, Gupta S, Rogers JS, Dickens M, Han J, Ulevitch RJ, Davis RJ.; ''Pro-inflammatory cytokines and environmental stress cause p38 mitogen-activated protein kinase activation by dual phosphorylation on tyrosine and threonine.''; PubMed Europe PMC Scholia
  24. Stafford MJ, Morrice NA, Peggie MW, Cohen P.; ''Interleukin-1 stimulated activation of the COT catalytic subunit through the phosphorylation of Thr290 and Ser62.''; PubMed Europe PMC Scholia
  25. Yamaguchi K, Shirakabe K, Shibuya H, Irie K, Oishi I, Ueno N, Taniguchi T, Nishida E, Matsumoto K.; ''Identification of a member of the MAPKKK family as a potential mediator of TGF-beta signal transduction.''; PubMed Europe PMC Scholia
  26. Mizukami Y, Yoshioka K, Morimoto S, Yoshida Ki.; ''A novel mechanism of JNK1 activation. Nuclear translocation and activation of JNK1 during ischemia and reperfusion.''; PubMed Europe PMC Scholia
  27. Beinke S, Deka J, Lang V, Belich MP, Walker PA, Howell S, Smerdon SJ, Gamblin SJ, Ley SC.; ''NF-kappaB1 p105 negatively regulates TPL-2 MEK kinase activity.''; PubMed Europe PMC Scholia
  28. Yoon S, Seger R.; ''The extracellular signal-regulated kinase: multiple substrates regulate diverse cellular functions.''; PubMed Europe PMC Scholia
  29. Thiefes A, Wolter S, Mushinski JF, Hoffmann E, Dittrich-Breiholz O, Graue N, Dörrie A, Schneider H, Wirth D, Luckow B, Resch K, Kracht M.; ''Simultaneous blockade of NFkappaB, JNK, and p38 MAPK by a kinase-inactive mutant of the protein kinase TAK1 sensitizes cells to apoptosis and affects a distinct spectrum of tumor necrosis factor [corrected] target genes.''; PubMed Europe PMC Scholia
  30. Banerjee A, Gerondakis S.; ''Coordinating TLR-activated signaling pathways in cells of the immune system.''; PubMed Europe PMC Scholia
  31. McLaughlin MM, Kumar S, McDonnell PC, Van Horn S, Lee JC, Livi GP, Young PR.; ''Identification of mitogen-activated protein (MAP) kinase-activated protein kinase-3, a novel substrate of CSBP p38 MAP kinase.''; PubMed Europe PMC Scholia
  32. Meng W, Swenson LL, Fitzgibbon MJ, Hayakawa K, Ter Haar E, Behrens AE, Fulghum JR, Lippke JA.; ''Structure of mitogen-activated protein kinase-activated protein (MAPKAP) kinase 2 suggests a bifunctional switch that couples kinase activation with nuclear export.''; PubMed Europe PMC Scholia
  33. Shi P, Zhu S, Lin Y, Liu Y, Liu Y, Chen Z, Shi Y, Qian Y.; ''Persistent stimulation with interleukin-17 desensitizes cells through SCFβ-TrCP-mediated degradation of Act1.''; PubMed Europe PMC Scholia
  34. Clifton AD, Young PR, Cohen P.; ''A comparison of the substrate specificity of MAPKAP kinase-2 and MAPKAP kinase-3 and their activation by cytokines and cellular stress.''; PubMed Europe PMC Scholia
  35. Waterfield MR, Zhang M, Norman LP, Sun SC.; ''NF-kappaB1/p105 regulates lipopolysaccharide-stimulated MAP kinase signaling by governing the stability and function of the Tpl2 kinase.''; PubMed Europe PMC Scholia
  36. Chang L, Karin M.; ''Mammalian MAP kinase signalling cascades.''; PubMed Europe PMC Scholia
  37. Bardwell AJ, Frankson E, Bardwell L.; ''Selectivity of docking sites in MAPK kinases.''; PubMed Europe PMC Scholia
  38. Lutz C, Nimpf J, Jenny M, Boecklinger K, Enzinger C, Utermann G, Baier-Bitterlich G, Baier G.; ''Evidence of functional modulation of the MEKK/JNK/cJun signaling cascade by the low density lipoprotein receptor-related protein (LRP).''; PubMed Europe PMC Scholia
  39. Roget K, Ben-Addi A, Mambole-Dema A, Gantke T, Yang HT, Janzen J, Morrice N, Abbott D, Ley SC.; ''IκB kinase 2 regulates TPL-2 activation of extracellular signal-regulated kinases 1 and 2 by direct phosphorylation of TPL-2 serine 400.''; PubMed Europe PMC Scholia
  40. Krappmann D, Hatada EN, Tegethoff S, Li J, Klippel A, Giese K, Baeuerle PA, Scheidereit C.; ''The I kappa B kinase (IKK) complex is tripartite and contains IKK gamma but not IKAP as a regular component.''; PubMed Europe PMC Scholia
  41. White A, Pargellis CA, Studts JM, Werneburg BG, Farmer BT.; ''Molecular basis of MAPK-activated protein kinase 2:p38 assembly.''; PubMed Europe PMC Scholia
  42. Sato S, Sanjo H, Takeda K, Ninomiya-Tsuji J, Yamamoto M, Kawai T, Matsumoto K, Takeuchi O, Akira S.; ''Essential function for the kinase TAK1 in innate and adaptive immune responses.''; PubMed Europe PMC Scholia
  43. Lamothe B, Besse A, Campos AD, Webster WK, Wu H, Darnay BG.; ''Site-specific Lys-63-linked tumor necrosis factor receptor-associated factor 6 auto-ubiquitination is a critical determinant of I kappa B kinase activation.''; PubMed Europe PMC Scholia
  44. Rothwarf DM, Zandi E, Natoli G, Karin M.; ''IKK-gamma is an essential regulatory subunit of the IkappaB kinase complex.''; PubMed Europe PMC Scholia

History

View all...
CompareRevisionActionTimeUserComment
114752view16:24, 25 January 2021ReactomeTeamReactome version 75
113196view11:26, 2 November 2020ReactomeTeamReactome version 74
112421view15:36, 9 October 2020ReactomeTeamReactome version 73
101325view11:21, 1 November 2018ReactomeTeamreactome version 66
100862view20:53, 31 October 2018ReactomeTeamreactome version 65
100403view19:27, 31 October 2018ReactomeTeamreactome version 64
99951view16:12, 31 October 2018ReactomeTeamreactome version 63
99507view14:44, 31 October 2018ReactomeTeamreactome version 62 (2nd attempt)
99152view12:41, 31 October 2018ReactomeTeamreactome version 62
93984view13:49, 16 August 2017ReactomeTeamreactome version 61
93588view11:28, 9 August 2017ReactomeTeamreactome version 61
87875view12:14, 25 July 2016RyanmillerOntology Term : 'kinase mediated signaling pathway' added !
87874view12:13, 25 July 2016RyanmillerOntology Term : 'signaling pathway pertinent to immunity' added !
87873view12:12, 25 July 2016RyanmillerOntology Term : 'signaling pathway' added !
86696view09:24, 11 July 2016ReactomeTeamreactome version 56
83420view11:11, 18 November 2015ReactomeTeamVersion54
81623view13:10, 21 August 2015ReactomeTeamVersion53
78712view14:27, 18 January 2015EgonwRemoved @GroupRefs to a that didn't exist in the GPML.
77083view08:38, 17 July 2014ReactomeTeamFixed remaining interactions
76788view12:15, 16 July 2014ReactomeTeamFixed remaining interactions
76111view10:17, 11 June 2014ReactomeTeamRe-fixing comment source
75823view11:38, 10 June 2014ReactomeTeamReactome 48 Update
75173view14:12, 8 May 2014AnweshaFixing comment source for displaying WikiPathways description
74820view08:55, 30 April 2014ReactomeTeamNew pathway

External references

DataNodes

View all...
NameTypeDatabase referenceComment
ADPMetaboliteCHEBI:16761 (ChEBI)
ATPMetaboliteCHEBI:15422 (ChEBI)
Activated TAK complexesComplexREACT_23279 (Reactome)
IKBKG ProteinQ9Y6K9 (Uniprot-TrEMBL)
K63polyUb TRAF6 ProteinQ9Y4K3 (Uniprot-TrEMBL)
MAP2K3 Protein
MAP2K6 Protein
MAP3K7 ProteinO43318 (Uniprot-TrEMBL)
MAPK targets/ Nuclear events mediated by MAP kinasesPathwayREACT_21328 (Reactome) MAPKs are protein kinases that, once activated, phosphorylate their specific cytosolic or nuclear substrates at serine and/or threonine residues. Such phosphorylation events can either positively or negatively regulate substrate, and thus entire signaling cascade activity.

The major cytosolic target of activated ERKs are RSKs (90 kDa Ribosomal protein S6 Kinase). Active RSKs translocates to the nucleus and phosphorylates such factors as c-Fos(on Ser362), SRF (Serum Response Factor) at Ser103, and CREB (Cyclic AMP Response Element-Binding protein) at Ser133. In the nucleus activated ERKs phosphorylate many other targets such as MSKs (Mitogen- and Stress-activated protein kinases), MNK (MAP interacting kinase) and Elk1 (on Serine383 and Serine389). ERK can directly phosphorylate CREB and also AP-1 components c-Jun and c-Fos. Another important target of ERK is NF-KappaB. Recent studies reveals that nuclear pore proteins are direct substrates for ERK (Kosako H et al, 2009). Other ERK nuclear targets include c-Myc, HSF1 (Heat-Shock Factor-1), STAT1/3 (Signal Transducer and Activator of Transcription-1/3), and many more transcription factors.

Activated p38 MAPK is able to phosphorylate a variety of substrates, including transcription factors STAT1, p53, ATF2 (Activating transcription factor 2), MEF2 (Myocyte enhancer factor-2), protein kinases MSK1, MNK, MAPKAPK2/3, death/survival molecules (Bcl2, caspases), and cell cycle control factors (cyclin D1).

JNK, once activated, phosphorylates a range of nuclear substrates, including transcription factors Jun, ATF, Elk1, p53, STAT1/3 and many other factors. JNK has also been shown to directly phosphorylate many nuclear hormone receptors. For example, peroxisome proliferator-activated receptor 1 (PPAR-1) and retinoic acid receptors RXR and RAR are substrates for JNK. Other JNK targets are heterogeneous nuclear ribonucleoprotein K (hnRNP-K) and the Pol I-specific transcription factor TIF-IA, which regulates ribosome synthesis. Other adaptor and scaffold proteins have also been characterized as nonnuclear substrates of JNK.

MAPK1 ProteinP28482 (Uniprot-TrEMBL)
MAPK11 ProteinQ15759 (Uniprot-TrEMBL)
MAPK14 ProteinQ16539 (Uniprot-TrEMBL)
MAPK1ProteinP28482 (Uniprot-TrEMBL)
MAPK3 ProteinP27361 (Uniprot-TrEMBL)
MAPK3ProteinP27361 (Uniprot-TrEMBL)
MAPK8/9/10ProteinREACT_21895 (Reactome)
MAPKAPK2 ProteinP49137 (Uniprot-TrEMBL)
MAPKAPK3 ProteinQ16644 (Uniprot-TrEMBL)
MDP MetaboliteCHEBI:59414 (ChEBI)
MEK1 ERK-1ComplexREACT_5539 (Reactome)
MEK1ProteinREACT_2607 (Reactome)
MEK2 ERK-2ComplexREACT_5435 (Reactome)
MKK3/MKK6ComplexREACT_21767 (Reactome)
MKK4/MKK7ProteinREACT_21423 (Reactome)
NOD1 ProteinQ9Y239 (Uniprot-TrEMBL)
NOD2 ProteinQ9HC29 (Uniprot-TrEMBL)
TAB1 ProteinQ15750 (Uniprot-TrEMBL)
TAB2 ProteinQ9NYJ8 (Uniprot-TrEMBL)
TAB3ProteinQ8N5C8 (Uniprot-TrEMBL)
Ub-209-RIPK2 ProteinO43353 (Uniprot-TrEMBL)
iE-DAP MetaboliteCHEBI:59271 (ChEBI)
p-2S,S376,T,T209,T387-IRAK1 ProteinP51617 (Uniprot-TrEMBL) This is the hyperphosphorylated, active form of IRAK1. The unknown coordinate phosphorylation events are to symbolize the multiple phosphorylations that likely take place in the ProST domain (aa10-211).
p-IRAK2 ProteinO43187 (Uniprot-TrEMBL)
p-MAP2K4/p-MAP2K7ProteinREACT_21783 (Reactome)
p-MAPK8/9/10ProteinREACT_21549 (Reactome)
p-MAPK8/9/10ProteinREACT_22035 (Reactome)
p-MEK1ProteinREACT_3339 (Reactome)
p-MKK3/p-MKK6ComplexREACT_21457 (Reactome)
p-MKK3/p-MKK6ComplexREACT_21595 (Reactome)
p-S,2T-MAPKAPK3 ProteinQ16644 (Uniprot-TrEMBL)
p-S,T-MAP2K2 ProteinP36507 (Uniprot-TrEMBL)
p-S,T-MAP2K2ProteinP36507 (Uniprot-TrEMBL)
p-S189,T193-MAP2K3 Protein
p-S207,T211-MAP2K6 Protein
p-S218,S222-MAP2K1 ProteinQ02750 (Uniprot-TrEMBL)
p-S218,S222-MAP2K1ProteinQ02750 (Uniprot-TrEMBL)
p-T161-CDK1ProteinP06493 (Uniprot-TrEMBL)
p-T180,Y182-MAPK11 ProteinQ15759 (Uniprot-TrEMBL)
p-T180,Y182-MAPK14 ProteinQ16539 (Uniprot-TrEMBL)
p-T184,T187-MAP3K7 ProteinO43318 (Uniprot-TrEMBL)
p-T185,Y187-MAPK1 ProteinP28482 (Uniprot-TrEMBL)
p-T185,Y187-MAPK1ProteinP28482 (Uniprot-TrEMBL)
p-T202,Y204-MAPK3 ProteinP27361 (Uniprot-TrEMBL)
p-T202,Y204-MAPK3ProteinP27361 (Uniprot-TrEMBL)
p-T222,S272,T334-MAPKAPK2 ProteinP49137 (Uniprot-TrEMBL)
p38 MAPK MAPKAPK2/3ComplexREACT_22059 (Reactome)
phospho-ERK-1 MEK1ComplexREACT_2796 (Reactome)
phospho-ERK-1 dimerComplexREACT_3152 (Reactome)
phospho-ERK-1 dimerComplexREACT_3932 (Reactome)
phospho-ERK-2 MEK2ComplexREACT_3199 (Reactome)
phospho-ERK-2 dimerComplexREACT_3688 (Reactome)
phospho-ERK-2 dimerComplexREACT_5046 (Reactome)
phospho-p38 MAPK MAPKAPK2/3ComplexREACT_21530 (Reactome)
phospho-p38 MAPK p-MAPKAPK2/3ComplexREACT_21539 (Reactome)
phospho-p38 MAPK phospho MAPKAPK2 or phospho MaPKAPK3ComplexREACT_21519 (Reactome)

Annotated Interactions

View all...
SourceTargetTypeDatabase referenceComment
ADPArrowREACT_136 (Reactome)
ADPArrowREACT_1836 (Reactome)
ADPArrowREACT_21338 (Reactome)
ADPArrowREACT_21367 (Reactome)
ADPArrowREACT_21375 (Reactome)
ADPArrowREACT_21395 (Reactome)
ADPArrowREACT_2247 (Reactome)
ADPArrowREACT_6896 (Reactome)
ATPREACT_136 (Reactome)
ATPREACT_1836 (Reactome)
ATPREACT_21338 (Reactome)
ATPREACT_21367 (Reactome)
ATPREACT_21375 (Reactome)
ATPREACT_21395 (Reactome)
ATPREACT_2247 (Reactome)
ATPREACT_6896 (Reactome)
Activated TAK complexesmim-catalysisREACT_21338 (Reactome)
Activated TAK complexesmim-catalysisREACT_21367 (Reactome)
MAPK1REACT_495 (Reactome)
MAPK3REACT_1780 (Reactome)
MAPK8/9/10REACT_6896 (Reactome)
MEK1 ERK-1REACT_136 (Reactome)
MEK1 ERK-1mim-catalysisREACT_136 (Reactome)
MEK1REACT_1836 (Reactome)
MEK2 ERK-2REACT_2247 (Reactome)
MEK2 ERK-2mim-catalysisREACT_2247 (Reactome)
MKK3/MKK6REACT_21338 (Reactome)
MKK4/MKK7REACT_21367 (Reactome)
REACT_1019 (Reactome) MEK2 dissociates from phospho-ERK2, allowing phospho-ERK2 to dimerise with another phospho-ERK2.
REACT_1289 (Reactome) Two phospho-ERK1 molecules dimerise and enter the nucleus, where they may phosphorylate downstream targets.
REACT_136 (Reactome) MEK1 phosphorylates the critical Tyrosine and Threonine on ERK1, converting two ATP to ADP. Phosphorylation of ERK-1 activates its kinase activity.
REACT_1740 (Reactome) MEK1 dissociates from phospho-ERK1, allowing phospho-ERK1 to dimerise with another phospho-ERK1.
REACT_1780 (Reactome) In the cytoplasm activated MEK1 (Serine phosphorylated) may encounter monomeric, inactive ERK1. ERK1 in its inactive form is not phosphorylated on a critical Threonine (T) and a critical Tyrosine (Y).
REACT_1836 (Reactome) At the beginning of this reaction, 2 molecules of 'ATP', and 1 molecule of 'MEK1' are present. At the end of this reaction, 1 molecule of 'phospho_MEK1', and 2 molecules of 'ADP' are present.

This reaction takes place in the 'cytosol' and is mediated by the 'protein serine/threonine kinase activity' of 'phospho-Cdc2 (Thr 161)'.

REACT_1866 (Reactome) Phospho-ERK-1 dimer is translocated from cytosol to nucleoplasm.
REACT_21299 (Reactome) The p38 activators MKK3 and MKK6 were present in both the nucleus and the cytoplasm, consistent with a role in activating p38 in the nucleus.
REACT_21338 (Reactome) Human MKK3 and MKK6 are two closely related dual-specificity protein kinases. Both are activated by cellular stress and inflammatory cytokines, and both phosphorylate and activate p38 MAP kinase at its activation site Thr-Gly-Tyr but do not phosphorylate or activate Erk1/2 or SAPK/JNK.

Activation of MKK3 and MKK6 occurs through phosphorylation of serine and threonine residues at the typical Ser-Xaa-Ala-Xaa-Thr motif in their activation loop. Residues involved into these protein kinases activation correspond to human sites Ser189 and Thr193 for MKK3 and Ser207 and Thr211 for MKK6 .

REACT_21358 (Reactome) p38 MAPK alpha does not have a nuclear export signal (NES) and cannot leave the nucleus by itself, but rather needs to be associated with MAP kinase-activated protein kinase 2 (MAPKAPK2 or MK2). The NES of MAPKAPK2 facilitates the transport of both kinases from the nucleus to the cytoplasm but only after MK2 has been phosphorylated by p38alpha.

p38 MAPK alpha phosphorylates MK2 at Thr222, Ser272, and Thr334. The phosphorylation of Thr334 but not the kinase activity of MK2 has been demonstrated to be critical for the nuclear export of the p38 alpha - MK2 complex. Phosphorylation of Thr334 is believed to induce a conformational change in the complex exposing NES prior to interaction with the leptomycin B-sensitive nuclear export receptor.

REACT_21367 (Reactome) In human, phosphorylation of MKK4 and MKK7 by TAK1 occurs at the typical Ser-Xaa-Ala-Xaa-Thr motif in their activation loops.

Residues involved in activation of these protein kinases correspond to human Ser271, Thr275 in MKK7 and Ser257, Thr261 in MKK4.

Cell lines lacking MKK4 exhibit defective activation of JNK and AP-1 dependent transcription activity in response to some cellular stresses; JNK and p38 MAPK activities were decreased by around 80% and 20%, respectively, following deletion of the mkk4 gene.

REACT_21375 (Reactome) Human p38 MAPK alpha forms a complex with MK2 even when the signaling pathway is not activated. This heterodimer is found mainly in the nucleus. The crystal structure of the unphosphorylated p38alpha-MK2 heterodimer was determined. The C-terminal regulatory domain of MK2 binds in the docking groove of p38 MAPK alpha, and the ATP-binding sites of both kinases are at the heterodimer interface.

Upon activation, p38 MAPK alpha activates MK2 by phosphorylating Thr-222, Ser-272, and Thr-334.

The phosphorylation of MK2 at Thr-334 attenuates the affinity of the binary complex MK2:p38 alpha by an order of magnitude and leads to a large conformational change of an autoinhibitory domain in MK2. This conformational change unmasks not only the MK2 substrate-binding site but also the MK2 nuclear export signal (NES) thus leading to the MK2:p38 alpha translocation from the nucleus to the cytoplasm. Cytoplasmic, active MK2 then phosphorylates downstream targets such as the heat-shock protein HSP27 and tristetraprolin (TTP).

MAPKAPK (MAPK-activated protein) kinase 3 (MK3, also known as 3pK) has been identified as the second p38 MAPK-activated kinase that is stimulated by different stresses (McLaughlin et al. 1996; Sithanandam et al. 1996; reviewed in Gaestel 2006). MK3 shows 75% sequence identity to MK2 and, like MK2, is activated by p38 MAPK alpha and p38 MAPK beta. MK3 phosphorylates peptide substrates with kinetic constants similar to MK2 and phosphorylates the same serine residues in HSP27 at the same relative rates as MK2 (Clifton et al. 1996) indicating an identical phosphorylation-site consensus sequence. Hence, it is assumed that its substrate spectrum is either identical to or at least overlapping with MK2.

REACT_21385 (Reactome) c-Jun NH2 terminal kinase (JNK) plays a role in conveying signals from the cytosol to the nucleus, where they associate and activate their target transcription factors.
REACT_21395 (Reactome) The MAPK level components of this cascade are p38MAPK-alpha, -beta, -gamma and -sigma. All of those isoforms are activated by phosphorylation of the Thr and Tyr in the Thr-Gly-Tyr motif in their activation loops.
REACT_2196 (Reactome) Two phospho-ERK2 molecules dimerise and enter the nucleus, where they may phosphorylate downstream targets.
REACT_2247 (Reactome) MEK2 phosphorylates the critical Tyrosine and Threonine on ERK2, converting two ATP to ADP. Phosphorylation of ERK-2 activates its kinase activity.
REACT_487 (Reactome) Phospho-ERK-2 dimer is translocated from cytosol to nucleoplasm.
REACT_495 (Reactome) In the cytoplasm activated MEK2 (Serine phosphorylated) may encounter monomeric, inactive ERK2. ERK2 in its inactive form is not phosphorylated on a critical Threonine (T183) and a critical Tyrosine (Y185).
REACT_6896 (Reactome) Activated human JNK kinases (MKK4 and MKK7) phosphorylate Thr183 and Tyr185 residues in the characteristic Thr-Pro-Tyr phosphoacceptor loop of each JNK.

JNK is differentially regulated by MKK4 and MKK7 depending on the stimulus. MKK7 is the primary activator of JNK in TNF, LPS, and PGN responses. However, TLR3 cascade requires both MKK4 and MKK7. Some studies reported that in three JNK isoforms tested MKK4 shows a striking preference for the tyrosine residue (Tyr-185), and MKK7 a striking preference for the threonine residue (Thr-183).

p-MAP2K4/p-MAP2K7ArrowREACT_21367 (Reactome)
p-MAP2K4/p-MAP2K7mim-catalysisREACT_6896 (Reactome)
p-MAPK8/9/10ArrowREACT_6896 (Reactome)
p-MEK1ArrowREACT_1836 (Reactome)
p-MEK1TBarREACT_136 (Reactome)
p-MKK3/p-MKK6ArrowREACT_21338 (Reactome)
p-MKK3/p-MKK6mim-catalysisREACT_21395 (Reactome)
p-S,T-MAP2K2ArrowREACT_1019 (Reactome)
p-S,T-MAP2K2REACT_495 (Reactome)
p-S218,S222-MAP2K1ArrowREACT_1740 (Reactome)
p-S218,S222-MAP2K1REACT_1780 (Reactome)
p-T161-CDK1mim-catalysisREACT_1836 (Reactome)
p-T185,Y187-MAPK1ArrowREACT_1019 (Reactome)
p-T202,Y204-MAPK3ArrowREACT_1740 (Reactome)
p38 MAPK MAPKAPK2/3REACT_21395 (Reactome)
phospho-ERK-1 MEK1ArrowREACT_136 (Reactome)
phospho-ERK-2 MEK2ArrowREACT_2247 (Reactome)
phospho-p38 MAPK MAPKAPK2/3ArrowREACT_21395 (Reactome)
phospho-p38 MAPK MAPKAPK2/3REACT_21375 (Reactome)
phospho-p38 MAPK MAPKAPK2/3mim-catalysisREACT_21375 (Reactome)
phospho-p38 MAPK p-MAPKAPK2/3ArrowREACT_21375 (Reactome)

Retrieved from "https://classic.wikipathways.org/index.php/Pathway:WP2792"
Personal tools